Multiple Myeloma Patients and Survivors Must use the Best of Both Conventional (FDA approved) and Evidence-based Non-Conventional Therapies. You’ve been diagnosed with Multiple Myeloma (MM). Your
Continue reading…open and unrestricted communication is vital in preserving the patient-doctor relationship and ensuring proper treatment .
Continue readingHeart failure (HF) is an increasingly prevalent health problem affecting more than 15 million of patients worldwide.1… it still has a poor prognosis.2, 3 Only 35% of patients will survive within
Continue readingSurvivors of breast cancer, prostate cancer, and childhood leukemia are at particularly high risk for changes in bone mineral density (BMD) / osteoporosis that can lead to fractures. In breast and prostate
Continue reading“A recent study showed approximately one-fifth of patients with cancer (myeloma) experienced post-traumatic stress disorder (PTSD) several months after diagnosis, and many of these patients continued
Continue readingGenetic Markers may Signal an Increased Risk of Cancer. At the Same Time Nutrition, Supplementation and Lifestyle Can Reduce your Risk of the same Cancer… I was diagnosed with multiple myeloma in
Continue readingMeta analyses demonstrate that Cardiac Rehabilitation reduces CVD mortal- ity and hospital admissions and improves health-related quality of life in patients with coronary heart disease. Ouch. According
Continue readingIncidence and mortality of multiple myeloma are 2-fold among Blacks than Whites…Age-adjusted incidence in African-Americans 9.5 per 100,000 per year and 4.1 per 100,00 per year in whites. While multiple
Continue readingMultiple Myeloma patients prevalently describe numbness/tingling in hands and feet, burning pain, altered sensitivity to touch and heat, muscle weakness, skin or nail changes, and/or lack of coordination. As
Continue reading“Patients with myeloid malignancies who have vitamin D deficiency prior to allogeneic stem cell transplantation (alloSCT) have an increased risk of relapse It is standard therapy for newly diagnosed
Continue reading“Thus, it seems that Velcade (bortezomib) is able to significantly overcome the poor prognosis of t(4;14) …Curcumin and bortezomib could exert synergistic effects on Multiple Myeloma cells,
Continue readingMultiple myeloma is identified because malignant plasma cells grow uncontrollably producing an antibody, which can be detected as a paraprotein. If you are reading this page, you may be wondering why
Continue reading